Glacier Bancorp vs Peoples Bancorp
GBCI and PEBO side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GBCI and PEBO compare
Glacier Bancorp is the larger company, worth 4.5 times as much as Peoples Bancorp ($6.1B against $1.4B).
On earnings, Peoples Bancorp is cheaper: it trades at 11.1× trailing earnings, against 19.2× for Glacier Bancorp.
Glacier Bancorp grew revenue faster over the last twelve months (14.3% versus 2.8% for Peoples Bancorp).
Glacier Bancorp keeps more of each dollar of sales as profit, with a net margin of 286% compared with 136% at Peoples Bancorp.
Both pay dividends: Glacier Bancorp yields 2.9% and Peoples Bancorp 4.4%.
Peoples Bancorp scores higher on the StockData Score (15 against 11 for Glacier Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GBCI | PEBO |
|---|---|---|
| Size and price | ||
| Market cap | $6.1B | $1.4B |
| Share price | $46.89 | $37.70 |
| Change, 1 year | 10.7% | 29.7% |
| Change, 5 years | −15.7% | 20.2% |
| Beta (5Y) | 0.35 | 0.03 |
| Employees | 4,188 | 1,454 |
| StockData Score | ||
| Total score | 11 | 15 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 2 | 4 (better) |
| Health score | 2 | 4 (better) |
| Dividend score | 4 | 5 (better) |
| Valuation | ||
| P/E | 19.2× | 11.1× (better) |
| P/S | 55.9× | 15.2× (better) |
| P/B | 1.4× | 1.1× (better) |
| EV/EBITDA | – | 11.5× |
| P/FCF | 15.0× | 7.9× (better) |
| FCF yield | 6.7% | 12.6% (better) |
| Fair value | $43.05 | $37.31 |
| Margin of safety | −8.9% | −1.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 14.3% (better) | 2.8% |
| Revenue growth, 5Y average | 13.1% (better) | 10.0% |
| Net income growth (TTM) | 41.6% (better) | 19.0% |
| EPS growth (TTM) | 27.1% (better) | 18.5% |
| EPS growth, 5Y average | −6.7% | 11.6% (better) |
| Profitability | ||
| Operating margin | – | 171% |
| Net margin | 286% (better) | 136% |
| FCF margin | 373% (better) | 192% |
| Return on equity | 7.9% | 10.1% (better) |
| Return on invested capital | – | 7.7% |
| Financial health | ||
| Debt / equity | – | 0.57 |
| Net debt / EBITDA | – | 2.65 |
| Altman Z-score | 0.19 | 0.23 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 2.9% | 4.4% (better) |
| Payout ratio | 54.0% | 49.1% |
| Years of dividend growth | 0 | 8 (better) |
| Dividend growth, 5Y average | −0.15% | 3.5% (better) |
| Buyback yield | – | −0.07% |
| Shareholder yield | 2.9% | 4.4% (better) |
| Ownership | ||
| Held by institutions | 86.5% | 66.0% |
| Held by insiders | 0.65% | 3.8% |
| Insider net buying, 12 months | $115K (better) | −$455K |
| Short interest, % of float | 7.4% | 8.4% |
Go deeper
- GBCI stock overview
- GBCI income statement
- GBCI valuation and score
- PEBO stock overview
- PEBO income statement
- PEBO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.